• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMET UK LTD. CER OPTION TYPE 1 TPR SLEVE +3; HIP ARTHROPLASTY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMET UK LTD. CER OPTION TYPE 1 TPR SLEVE +3; HIP ARTHROPLASTY Back to Search Results
Model Number N/A
Medical Device Problem Code Insufficient Device Problem Information (3190)
Health Effect - Clinical Codes Unspecified Infection (1930); No Known Impact Or Consequence To Patient (2692)
Date of Event 12/27/2019
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
(b)(4).Concomitant medical products: medical product: cer bioloxd option hd 36mm, catalog #: 650-1057, lot #: 2958828, medical product: g7 neutral e1 liner 36mm e, catalog #: 010000857, lot #: 6515598.Multiple mdr reports were filed for this event, please see associated reports: 3002806535-2020-00045.The investigation is in process.Once the investigation has been completed, a follow-up mdr will be submitted.
 
Event or Problem Description
It was reported that patient underwent total hip arthroplasty.Subsequently, the patient underwent irrigation and debridement, where the liner and head components were removed and replaced.
 
Additional Manufacturer Narrative
(b)(4).Multiple mdr reports were filed for this event, please see associated report: 3002806535-2020-00045.As the product has not been received, the investigation was limited to the information provided; a review of device history records and complaint history.From the received response, the cause and type of the infection could not be confirmed.The action taken to cure the infection was to perform a head and liner swap with an irrigation debridement technique of surrounding tissues in hip.A review of the manufacturing history records confirms no abnormalities or deviations reported.The sterilisation certificates were reviewed and confirmed that product is sterilised within the specification range.Without the opportunity to examine the complaint product, root cause cannot be determined due to insufficient information.If any further information is found which would change or alter any conclusions or information, a supplemental will be filed accordingly.Zimmer biomet will continue to monitor for trends.
 
Event or Problem Description
It was reported that patient underwent total hip arthroplasty.Subsequently, the patient underwent irrigation and debridement, where the liner and head components were removed and replaced.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CER OPTION TYPE 1 TPR SLEVE +3
Common Device Name
HIP ARTHROPLASTY
Manufacturer (Section D)
BIOMET UK LTD.
waterton industrial estates
bridgend CF31 3XA
UK  CF31 3XA
MDR Report Key9631497
Report Number3002806535-2020-00046
Device Sequence Number502088
Product Code LZO
UDI-Device Identifier00887868248689
UDI-Public00887868248689
Combination Product (Y/N)N
Initial Reporter StateTX
Initial Reporter CountryUS
PMA/510(K) Number
K082996
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2019
Device Explanted Year2019
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 02/06/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model NumberN/A
Device Catalogue Number650-1067
Device Lot Number2959173
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Initial Date Received by Manufacturer 12/31/2019
Supplement Date Received by Manufacturer01/28/2020
Initial Report FDA Received Date01/27/2020
Supplement Report FDA Received Date02/07/2020
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
If action reported to FDA under 21 USC 360i(g), list
FDA-assigned Recall Number or include a statement
N/A
Patient Sequence Number1
Outcome Attributed to Adverse Event Hospitalization; Required Intervention;
-
-